EDGAR Filing Documents for 0001493152-24-033579

Form 8-K - Current report:

SEC Accession No. 0001493152-24-033579

Filing Date

2024-08-22

Accepted

2024-08-22 17:16:09

Documents

Period of Report

2024-08-22

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	43742
2		ex99-1.htm	EX-99.1	18033
3		ex99-1_001.jpg	GRAPHIC	1251528
4		ex99-1_002.jpg	GRAPHIC	1856527
5		ex99-1_003.jpg	GRAPHIC	957978
6		ex99-1_004.jpg	GRAPHIC	931301
7		ex99-1_005.jpg	GRAPHIC	1237169
8		ex99-1_006.jpg	GRAPHIC	1177469
9		ex99-1_007.jpg	GRAPHIC	1123141
10		ex99-1_008.jpg	GRAPHIC	1182955
11		ex99-1_009.jpg	GRAPHIC	1105488
12		ex99-1_010.jpg	GRAPHIC	1146090
13		ex99-1_011.jpg	GRAPHIC	1087685
14		ex99-1_012.jpg	GRAPHIC	1007686
15		ex99-1_013.jpg	GRAPHIC	1209366
16		ex99-1_014.jpg	GRAPHIC	1185015
17		ex99-1_015.jpg	GRAPHIC	1006196
18		ex99-1_016.jpg	GRAPHIC	1333634
19		ex99-1_017.jpg	GRAPHIC	1154855
20		ex99-1_018.jpg	GRAPHIC	1550290
21		ex99-1_019.jpg	GRAPHIC	1211433
22		ex99-1_020.jpg	GRAPHIC	899851
23		ex99-1_021.jpg	GRAPHIC	1071400
24		ex99-1_022.jpg	GRAPHIC	953519
25		ex99-1_023.jpg	GRAPHIC	1143650
	Complete submission text file	0001493152-24-033579.txt		37132485

Data Files

Seq	Description	Document	Type	Size
26	XBRL SCHEMA FILE	cldi-20240822.xsd	EX-101.SCH	3813
27	XBRL DEFINITION FILE	cldi-20240822_def.xml	EX-101.DEF	26683
28	XBRL LABEL FILE	cldi-20240822_lab.xml	EX-101.LAB	36817
29	XBRL PRESENTATION FILE	cldi-20240822_pre.xml	EX-101.PRE	25307
40	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	6006

Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121

Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600

Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)